Y Kinjo Selected Research

Interleukin-18 (Interleukin 18)

11/2001	Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
7/2000	IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells.
5/2000	Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Y Kinjo Research Topics

Disease

6	Infections 05/2005 - 05/2000
1	Graves Disease (Basedow Disease) 06/2007
1	Cryptococcosis 11/2001
1	Teratocarcinoma 03/2001
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2001
1	Diabetes Mellitus 01/2001
1	Hypersensitivity (Allergy) 01/2000

Drug/Important Bio-Agent (IBA)

3	alpha-galactosylceramideIBA 12/2001 - 01/2001
3	Interleukin-18 (Interleukin 18)IBA 11/2001 - 05/2000
2	InterleukinsIBA 06/2007 - 05/2000
2	Interferon-gamma (Interferon, gamma)IBA 05/2005 - 11/2001
2	Interleukin-12 (IL 12)IBA 11/2001 - 07/2000
1	Immunoglobulin E (IgE)IBA 06/2007
1	CPG-oligonucleotideIBA 05/2005
1	OligodeoxyribonucleotidesIBA 05/2005
1	Chemotactic FactorsIBA 12/2001
1	Messenger RNA (mRNA)IBA 12/2001
1	Interleukin-4 (Interleukin 4)IBA 11/2001
1	LuciferasesIBA 03/2001
1	Codon (Codons)IBA 01/2001
1	Methionine (L-Methionine)FDA Link 01/2001
1	K-18 conjugate (K18)IBA 01/2001
1	SuperantigensIBA 01/2001
1	recombinant soluble CD4IBA 01/2000